Viewing Study NCT05246033


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-30 @ 12:57 PM
Study NCT ID: NCT05246033
Status: UNKNOWN
Last Update Posted: 2023-11-02
First Post: 2022-02-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
Sponsor: Ascendis Pharma A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module